Alabama Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (AL-SIGHT): Study Design and Methodology
- PMID: 33492893
- PMCID: PMC8084961
- DOI: 10.1097/IJG.0000000000001794
Alabama Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (AL-SIGHT): Study Design and Methodology
Abstract
Prcis: This paper presents the methods and protocol of a community-based telemedicine program to identify glaucoma and other eye diseases.
Purpose: To describe the study rationale and design of the Alabama Screening and Intervention for Glaucoma and eye Health through Telemedicine project.
Methods: The study will implement and evaluate a telemedicine-based detection strategy for glaucoma, diabetic retinopathy, and other eye diseases in at-risk patients seen at federally qualified health centers located in rural Alabama. The study will compare the effectiveness of the remote use of structural and functional ocular imaging devices to an in-person examination. Study participants will receive a remote ocular assessment consisting of visual acuity, intraocular pressure, visual field testing, and imaging of the retina and optic nerve with spectral-domain optical coherence tomography, and the data will be reviewed by an ophthalmologist and optometrist. It will also compare the effectiveness of financial incentives along with a validated patient education program versus a validated patient education program alone in improving follow-up adherence. Finally, cost and cost-effectiveness analyses will be performed on the telemedicine program compared with standard in-person care using effectiveness measured in numbers of detected eye disease cases.
Conclusions: The study aims to develop a model eye health system using telemedicine to prevent vision loss and address eye health among underserved and at-risk populations.
Trial registration: ClinicalTrials.gov NCT04328207.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors declare no conflict of interest.
Figures
Similar articles
-
Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Baseline Results.Am J Ophthalmol. 2024 Jan;257:66-75. doi: 10.1016/j.ajo.2023.09.001. Epub 2023 Sep 7. Am J Ophthalmol. 2024. PMID: 37683821
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (MI-SIGHT): Baseline Methodology for Implementing and Assessing a Community-based Program.J Glaucoma. 2021 May 1;30(5):380-387. doi: 10.1097/IJG.0000000000001812. J Glaucoma. 2021. PMID: 33596017 Free PMC article.
-
Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) for adults at risk for glaucoma: study rationale and design.Int J Equity Health. 2015 Nov 18;14:135. doi: 10.1186/s12939-015-0213-8. Int J Equity Health. 2015. PMID: 26582103 Free PMC article.
-
Screening for Glaucoma in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 May. Report No.: 21-05286-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 May. Report No.: 21-05286-EF-1. PMID: 35679438 Free Books & Documents. Review.
-
Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.Br J Ophthalmol. 2018 Nov;102(11):1485-1491. doi: 10.1136/bjophthalmol-2017-311452. Epub 2018 Apr 21. Br J Ophthalmol. 2018. PMID: 29680803
Cited by
-
Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine Program: Impact on Vision, Follow-up, and Costs.Ophthalmology. 2025 Sep;132(9):1033-1044. doi: 10.1016/j.ophtha.2025.04.027. Epub 2025 Apr 29. Ophthalmology. 2025. PMID: 40311700 Clinical Trial.
-
Surfing the COVID-19 Tsunami with Teleophthalmology: the Advent of New Models of Eye Care.Curr Ophthalmol Rep. 2023;11(1):1-12. doi: 10.1007/s40135-023-00308-9. Epub 2023 Jan 28. Curr Ophthalmol Rep. 2023. PMID: 36743397 Free PMC article. Review.
-
Telehealth and Screening Strategies in the Diagnosis and Management of Glaucoma.J Clin Med. 2021 Aug 4;10(16):3452. doi: 10.3390/jcm10163452. J Clin Med. 2021. PMID: 34441748 Free PMC article. Review.
-
Recruiting Populations at Higher Risk for Glaucoma and Other Eye Diseases Experiencing Eye Health Disparities.Ophthalmic Epidemiol. 2024 Jun;31(3):220-228. doi: 10.1080/09286586.2023.2232038. Epub 2023 Jul 5. Ophthalmic Epidemiol. 2024. PMID: 37408319 Free PMC article.
-
Identifying, Understanding, and Addressing Disparities in Glaucoma Care in the United States.Transl Vis Sci Technol. 2023 Oct 3;12(10):18. doi: 10.1167/tvst.12.10.18. Transl Vis Sci Technol. 2023. PMID: 37889504 Free PMC article.
References
-
- CentersforDiseaseControlandPrevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2020. Atlanta, GA: US Department of Health and Human Services.;2020.
-
- Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology. 2004;122:477–485. - PubMed
-
- Lee PP, Feldman ZW, Osterman J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Archives of Ophthalmology. 2003;121:1303–1310. - PubMed
-
- Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. The New England journal of medicine. 1991;325(20):1412–1417. - PubMed
-
- Prevention CfDCa. Underlying Cause of Death 1999–2018 on CDC WONDER Online Database, released in 2020. National Center for Health Statistics, Atlanta GA. http://wonder.cdc.gov/ucd-icd10.html. Accessed September 19, 2020.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical